168
Views
99
CrossRef citations to date
0
Altmetric
Review

The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO

, &
Pages 737-742 | Published online: 25 Oct 2016

References

  • HetlandMLUnkerskovJRavnTRoutine database registration of biological therapy increases the reporting of adverse events twentyfold in clinical practice. First results from the Danish Database (DANBIO)Scand J Rheumatol200534404415903024
  • SchefteDBHetlandMLAn open-source, self-explanatory touch screen in routine care. Validity of filling in the bath measures on ankylosing spondylitis disease activity index, function index, the health assessment questionnaire and visual analogue scales in comparison with paper versionsRheumatology2010499910419920097
  • LyngeESandegaardJLReboljMThe Danish national patient registerScand J Public Health Suppl2011397 suppl3033
  • DANBIO [homepage on the Internet]Danbio’s National Clinical Quality Report 2014 (Report in Danish) Available from: www.danbio-online.dkAccessed July 01, 2015
  • HetlandMLDANBIO – powerful research database and electronic patient recordRheumatology201150697721148154
  • HetlandMHJensenDVKroghNSMonitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registryClin Exp Rheumatol201432suppl 85141146
  • HetlandMLChristensenIJTarpUAll Departments of Rheumatology in DenmarkDirect comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registryArthritis Rheum2010621223220039405
  • ØrnbjergLMØstergaardMBøyesenPImpact of tumour necrosis factor inhibitor treatment on radiographic progression in rheumatoid arthritis patients in clinical practice: results from the nationwide Danish DANBIO registryAnn Rheum Dis2013721576322532636
  • GlintborgBØstergaardMDreyerLTreatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor α therapy: results from the nationwide Danish DANBIO registryArthritis Rheum201163238239021279995
  • GlintborgBOstergaardMKroghNSDreyerLKristensenHLHetlandMLPredictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years’ surveillance in the Danish nationwide DANBIO registryAnn Rheum Dis201069112002200820511613
  • DreyerLMellemkjærLAndersenARIncidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO registryAnn Rheum Dis2013721798222945500
  • CordtzRMellemkjærLGlintborgBHetlandMLDreyerLMalignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritisAnn Rheum Dis20157471479148025744102
  • HøjgaardPGlintborgBHetlandMLAssociation between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryAnn Rheum Dis201474122130213625063827